Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 31.10M | £ 27.40M | £ 26.80M | £ 28.30M | £ 30.40M |
Total Assets | £ 465.10M | £ 359.50M | £ 334.50M | £ 312.20M | £ 316.30M |
Total Debt | £ 115.40M | £ 42.80M | £ 49.50M | £ 42.00M | £ 64.30M |
Net Debt | £ 84.30M | £ 15.40M | £ 22.70M | £ 13.70M | £ 33.90M |
Total Liabilities | £ 250.60M | £ 159.20M | £ 167.20M | £ 163.70M | £ 205.90M |
Stockholders Equity | £ 214.50M | £ 200.30M | £ 167.30M | £ 148.50M | £ 110.40M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |